FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   Landgraf John C 2. Date of Event Requiring Statement (Month/Day/Year) 10/14/2013 3. Issuer Name and Ticker or Trading Symbol ABBOTT LABORATORIES [ABT] (Last) (First) (Middle) 100 ABBOTT PARK ROAD 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Executive Vice President 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) ABBOTT PARK, IL 60064-6400 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common shares without par value 105,306 D   Common shares without par value 18,398 (1) I Profit Sharing Trust Common shares without par value 166 (2) I By self for son

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy) (3)	02/16/2008	02/15/2017	Common shares	27,667	$ 25.2461	D	Â
Option (right to buy) (3)	02/16/2009	02/15/2017	Common shares	27,666	$ 25.2461	D	Â
Option (right to buy) (3)	02/16/2010	02/15/2017	Common shares	27,667	$ 25.2461	D	Â
Option (right to buy) (3)	02/15/2009	02/14/2018	Common shares	26,234	$ 26.6973	D	Â
Option (right to buy) (3)	02/15/2010	02/14/2018	Common shares	26,233	$ 26.6973	D	Â
Option (right to buy) (3)	02/15/2011	02/14/2018	Common shares	26,233	$ 26.6973	D	Â
Option (right to buy) (3)	02/20/2010	02/19/2019	Common shares	12,900	$ 26.015	D	Â
Option (right to buy) (3)	02/20/2011	02/19/2019	Common shares	12,900	$ 26.015	D	Â
Option (right to buy) (3)	02/20/2012	02/19/2019	Common shares	12,900	$ 26.015	D	Â
Option (right to buy) (4)	02/19/2011	02/18/2020	Common shares	9,567	$ 26.1879	D	Â
Option (right to buy) (4)	02/19/2012	02/18/2020	Common shares	9,566	$ 26.1879	D	Â
Option (right to buy) (4)	02/19/2013	02/18/2020	Common shares	9,567	$ 26.1879	D	Â
Option (right to buy) (4)	02/18/2012	02/17/2021	Common shares	16,700	$ 22.3919	D	Â
Option (right to buy) (4)	02/18/2013	02/17/2021	Common shares	16,700	$ 22.3919	D	Â
Option (right to buy) (4)	02/18/2014	02/17/2021	Common shares	16,700	$ 22.3919	D	Â
Option (right to buy) (4)	02/17/2013	02/16/2022	Common shares	18,334	$ 27.0336	D	Â
Option (right to buy) (4)	02/17/2014	02/16/2022	Common shares	18,333	$ 27.0336	D	Â
Option (right to buy) (4)	02/17/2015	02/16/2022	Common shares	18,333	$ 27.0336	D	Â
Option (right to buy) (4)	03/01/2013	08/02/2014	Common shares	6,247	$ 31.4255	D	Â
Option (right to buy) (4)	03/08/2013	02/19/2014	Common shares	21,972	$ 32.1559	D	Â
Option (right to buy) (4)	03/08/2013	08/02/2014	Common shares	11,956	$ 32.1559	D	Â
Option (right to buy) (4)	02/15/2014	02/14/2023	Common shares	55,000	$ 34.94	D	Â
Option (right to buy) (4)	02/15/2015	02/14/2023	Common shares	55,000	$ 34.94	D	Â
Option (right to buy) (4)	02/15/2016	02/14/2023	Common shares	55,000	$ 34.94	D	Â
Option (right to buy) (4)	02/17/2014	02/19/2014	Common shares	1,583	$ 35.03	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Landgraf John C 100 ABBOTT PARK ROAD ABBOTT PARK, IL 60064-6400	Â	Â	  Executive Vice President	Â

Signatures

John A. Berry, by power of attorney for John C. Landgraf		10/24/2013
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Balance in the Abbott Laboratories Stock Retirement Trust as of October 14, 2013.
(2)	The reporting person disclaims beneficial ownership of all securities held by his son.
(3)	Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
(4)	Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.